Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/28/2025
China Expands Grassroots Healthcare Access with More Doctors, Mobile S...
11/28/2025
Zhongmou Reports Strong First-in-Human Results for Optogenetic Gene Th...
11/28/2025
Recent Executive Moves
11/27/2025
Sugemalimab Wins European Approval for Stage III NSCLC
11/27/2025
CSPC's JMT206 Wins Green Light for First-in-Human Trials in China
11/27/2025
Biontech to Present Phase 2 Data for Bispecific Antibody Pumitamig in ...
11/27/2025
NMPA Approves AstraZeneca's Imfinzi for NSCLC in China
11/27/2025
Ascentage Pharma Publishes Phase Ib Data for Olverembatinib in GIST
11/27/2025
Novartis's Rhapsido Approved for Chronic Spontaneous Urticaria in Chin...
11/27/2025
GlobalData: Ivonescimab Poised to Transform China's TNBC Market
11/27/2025
Olymvax Files for Hong Kong Listing as Vaccine Pipeline Expands
11/27/2025
MC's China Biopharma Tracker: Dealmaking, Approvals, and $451 Million ...
11/25/2025
Reprogenix Raises CNY 500M in A+ Round to Push Forward First-In-China...
11/25/2025
Pfizer's Hympavzi (Marstacimab) Gains NMPA Approval in China
11/25/2025
BioCorteX and CD Biopharma Form Strategic Alliance to Accelerate Preci...
11/25/2025
Amicus Diversifies Manufacturing from China to Reduce Geopolitical Ris...
11/25/2025
Samsung LS Fund Invests in Phrontline to Boost ADC Development
11/25/2025
Kelun Reports Positive Phase 2 Results for Sac-TMT Combined with KEYTR...
11/25/2025
China Accelerates Investment in Nuclear Medicine Amid Global Radiophar...
11/21/2025
Innovent Moves Toward China Filing After High-Dose Obesity Drug Delive...
11/21/2025
Xiangxue Expands Into In Vivo TCR-T Therapy Through New Partnership
11/21/2025
Recent Executive Moves
11/21/2025
China's Biopharma Innovation Surges — McKinsey Lays Out Both Opportun...
11/20/2025
China's Innovation-drug BD Boom Slows as Investors Shift Focus to Prod...
11/20/2025
China Biopharma Tracker – October 2025 (PharmaDJ)
11/20/2025
China's Pharmaceutical Market Enters a New Consumer-Driven Era
11/20/2025
China Pilots Next-Generation AI Reforms Across Public Hospitals
11/20/2025
NHC Issues the Guidelines for Strengthening Service Capacity in Primar...
11/20/2025
Innovent's Mazdutide Achieves Strong Phase 3 Results in Chinese Obesit...
11/18/2025
TandemAI Raises $22M in Series A Extension to Advance AI...
Page:
1
/
373
Total number of articles:
11167
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit